禾信仪器(688622) - 2022 Q3 - 季度财报

Key Financial Data Key Accounting Data and Financial Indicators The company's performance significantly declined in Q3 and the first three quarters of 2022, marked by sharp revenue decrease, net profit turning to loss, and substantial R&D investment Key Financial Indicators for Q1-Q3 2022 | Indicator | Year-to-Date (2022 Q1-Q3) (RMB) | Prior Period (2021 Q1-Q3) (RMB) | YoY Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 150,909,898.71 | 240,696,767.81 | -37.30% | | Net Profit Attributable to Parent Company Shareholders | -43,820,669.08 | 39,288,298.33 | -211.54% | | Net Profit Attributable to Parent Company Shareholders Excluding Non-recurring Gains and Losses | -67,340,742.97 | 17,189,352.86 | -491.76% | | Net Cash Flow from Operating Activities | -83,509,479.68 | -61,168,444.46 | Not Applicable | | Basic Earnings Per Share (RMB/share) | -0.63 | 0.75 | -184.00% | | Total R&D Expenses | 52,476,192.85 | 32,648,604.01 | 60.73% | Key Financial Indicators for Q3 2022 | Indicator | Current Period (2022 Q3) (RMB) | Prior Period (2021 Q3) (RMB) | YoY Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 41,503,318.95 | 112,560,149.98 | -63.13% | | Net Profit Attributable to Parent Company Shareholders | -26,832,165.96 | 24,532,522.71 | -209.37% | | Total R&D Expenses | 21,257,190.25 | 12,427,982.22 | 71.04% | Non-recurring Gains and Losses Items and Amounts In the first three quarters of 2022, the company's total non-recurring gains and losses amounted to RMB 23.52 million, partially offsetting operating losses, with government grants being the largest component at RMB 26.38 million Non-recurring Gains and Losses Items for Q1-Q3 2022 | Item | Year-to-Date Amount (RMB) | | :--- | :--- | | Gains and Losses from Disposal of Non-current Assets | 1,478,395.15 | | Government Grants Included in Current Profit and Loss | 26,376,027.05 | | Gains and Losses from Entrusted Investment or Asset Management | 1,375,659.49 | | Other Non-operating Income and Expenses | -380,953.78 | | Total | 23,520,073.89 | Analysis of Changes in Key Financial Indicators The company explained significant changes in key financial indicators, attributing revenue and net profit declines primarily to pandemic-induced order delays, while increased R&D investment reflects a strategic choice to expand product lines and new product development - The primary reason for the year-on-year decrease in operating revenue is the delay in order acquisition due to the pandemic[11] - Key reasons for the significant decline in net profit include: 1) decreased operating revenue; 2) increased investment in new product R&D to enrich product lines; and 3) increased selling expenses due to market expansion efforts[11] - The substantial year-on-year increase in R&D investment is primarily due to higher R&D personnel salaries and material expenditures aimed at enriching product lines and investing in new products[12] Shareholder Information Shareholding Status As of September 30, 2022, the company had 4,129 common shareholders, with a relatively concentrated equity structure where the top two shareholders, Zhou Zhen and Fu Zhong, acting in concert, collectively hold over 34% of shares, and the top ten include several state-owned legal entities and investment institutions - As of the end of the reporting period, the company had 4,129 common shareholders[14] Shareholding Status of Top Five Shareholders | Shareholder Name | Shareholding Percentage (%) | Number of Shares Held (shares) | Shareholder Type | | :--- | :--- | :--- | :--- | | Zhou Zhen | 20.87 | 14,609,675 | Domestic Individual | | Fu Zhong | 13.52 | 9,465,447 | Domestic Individual | | Kunshan Guoke Venture Capital Co., Ltd. | 9.96 | 6,968,636 | State-owned Legal Person | | Gongqingcheng Tongce Investment Management Partnership | 8.63 | 6,040,000 | Other | | Yingfutaike Venture Capital Co., Ltd. | 6.64 | 4,645,760 | Domestic Non-state-owned Legal Person | - The company's controlling shareholders and actual controllers, Zhou Zhen and Fu Zhong, are concerted parties; additionally, Zhou Zhen effectively controls Gongqingcheng Tongce Investment Management Partnership[16] Other Reminders Other Important Information The company confirms no other significant operating information requires special investor attention during the reporting period - The company has no other important operating information requiring investor attention during the reporting period[17] Quarterly Financial Statements Consolidated Balance Sheet As of September 30, 2022, total assets were RMB 871 million, a 6.45% decrease from year-end, mainly due to reduced cash; total liabilities were RMB 335 million, largely unchanged; and total equity attributable to parent company shareholders was RMB 550 million, down 9.15% Key Items from Consolidated Balance Sheet | Item | September 30, 2022 (RMB) | December 31, 2021 (RMB) | Change (%) | | :--- | :--- | :--- | :--- | | Total Assets | 871,274,898.96 | 931,395,210.90 | -6.45% | | Cash and Cash Equivalents | 180,829,289.70 | 340,149,091.93 | -46.84% | | Total Liabilities | 335,085,757.18 | 338,112,699.44 | -0.90% | | Total Equity Attributable to Parent Company Shareholders | 549,779,329.11 | 605,122,842.16 | -9.15% | Consolidated Income Statement In the first three quarters of 2022, operating revenue was RMB 151 million, a 37.30% year-on-year decrease, leading to a RMB 43.82 million loss from a RMB 39.29 million profit in the prior period, driven by revenue decline and significant increases in selling and R&D expenses Key Items from Consolidated Income Statement (Q1-Q3 2022) | Item | Jan-Sep 2022 (RMB) | Jan-Sep 2021 (RMB) | YoY Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 150,909,898.71 | 240,696,767.81 | -37.30% | | Operating Cost | 63,773,953.57 | 103,889,438.25 | -38.61% | | Selling Expenses | 82,357,964.70 | 56,957,235.53 | 44.60% | | R&D Expenses | 52,476,192.85 | 32,648,604.01 | 60.73% | | Net Profit Attributable to Parent Company Shareholders | -43,820,669.08 | 39,288,298.33 | -211.54% | Consolidated Cash Flow Statement In the first three quarters of 2022, net cash outflow from operating activities increased to RMB 83.51 million due to reduced sales receipts and increased expenses, while investing activities had a net outflow of RMB 98.99 million and financing activities a net inflow of RMB 23.16 million, leading to a significant decrease in period-end cash and cash equivalents Key Items from Consolidated Cash Flow Statement (Q1-Q3 2022) | Item | Jan-Sep 2022 (RMB) | Jan-Sep 2021 (RMB) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | -83,509,479.68 | -61,168,444.46 | | Net Cash Flow from Investing Activities | -98,986,276.22 | -101,195,837.27 | | Net Cash Flow from Financing Activities | 23,155,178.25 | 332,762,702.78 | | Net Increase in Cash and Cash Equivalents | -159,340,577.65 | 170,398,421.05 |